Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Other Accumulated Expenses (2022 - 2024)

Historic Other Accumulated Expenses for Jin Medical International (ZJYL) over the last 3 years, with Q3 2024 value amounting to $8001.0.

  • Jin Medical International's Other Accumulated Expenses rose 2004.5% to $8001.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $8001.0, marking a year-over-year increase of 2004.5%. This contributed to the annual value of $8001.0 for FY2024, which is 2004.5% up from last year.
  • As of Q3 2024, Jin Medical International's Other Accumulated Expenses stood at $8001.0, which was up 2004.5% from $6665.0 recorded in Q3 2023.
  • In the past 5 years, Jin Medical International's Other Accumulated Expenses ranged from a high of $24729.0 in Q3 2022 and a low of $6665.0 during Q3 2023
  • Over the past 3 years, Jin Medical International's median Other Accumulated Expenses value was $8001.0 (recorded in 2024), while the average stood at $13131.7.
  • Per our database at Business Quant, Jin Medical International's Other Accumulated Expenses plummeted by 7304.78% in 2023 and then surged by 2004.5% in 2024.
  • Quarter analysis of 3 years shows Jin Medical International's Other Accumulated Expenses stood at $24729.0 in 2022, then tumbled by 73.05% to $6665.0 in 2023, then rose by 20.05% to $8001.0 in 2024.
  • Its Other Accumulated Expenses stands at $8001.0 for Q3 2024, versus $6665.0 for Q3 2023 and $24729.0 for Q3 2022.